DPGME is used as a solvent for paints, lacquers, resins, dyes, oil/greases, cleaners and cellulose and as a heat-transfer agent. It is frequently used as a substitute for the more toxic DEGME (diethylene glycol methyl ether). (Ref. 5.10).
The descriptions for the most commonly used codes to describe the administration of SIMPONI ARIAÂ® are: 96413 Chemotherapy administration, intravenous infusion technique, up to one hour, single or initial substance.
The BCR-ABL tyrosine kinase inhibitor (TKI) GleevecÂ® is FDA approved for adults with Ph positive CML in blast crisis phase, accelerated phase, or in chronic phase after failure of interferon alpha therapy. Other drug choices include Sprycel, Tasigna, Bosulif and Synribo. A clinical trial is another treatment choice.